Position in PFE
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$4,023,671
+$3,668,039 QoQ
Shares Held
167,096
+1219.4% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.17%
of 13F equity value
Holder Rank
#683
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Derivatives in PFE
reported options exposure · as of Mar 31, 2020CallValue
$2,000,829
CallShares
64,610
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026SNS Financial Group, LLC holds $152,677,395 across 10 Drug Manufacturers - General names. PFE ranks #5 (2.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
46,863 | $56,208,892 | |
| 2 | JNJ |
Johnson & Johnson
|
172,754 | $43,874,333 | |
| 3 | NVO |
Novo Nordisk A S
|
669,858 | $32,112,992 | |
| 4 | ABBV |
AbbVie Inc.
|
32,457 | $8,167,479 | |
| 5 | PFE |
Pfizer Inc
This page
|
167,096 | $4,023,671 | |
| 6 | MRK |
Merck & Co., Inc.
|
27,952 | $3,591,832 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
36,127 | $2,081,637 | |
| 8 | AMGN |
Amgen Inc
|
2,842 | $1,029,145 |
All Filings in PFE
Export CSV
27 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,023,671 | 167,096 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $355,632 | 12,665 | Shares | Defined | 2026-04-14 | |
| 2025-12-31 | $314,959 | 12,649 | Shares | Sole | 2026-02-02 | |
| 2025-09-30 | $367,217 | 14,412 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $354,097 | 14,608 | Shares | Sole | 2025-08-06 | |
| 2025-03-31 | $396,469 | 15,646 | Shares | Sole | 2025-05-05 | |
| 2024-12-31 | $344,465 | 12,984 | Shares | Defined | 2025-02-03 | |
| 2024-09-30 | $408,747 | 14,124 | Shares | Defined | 2024-11-01 | |
| 2024-06-30 | $558,983 | 19,978 | Shares | Sole | 2024-07-25 | |
| 2024-03-31 | $1,553,167 | 55,970 | Shares | Defined | 2024-04-24 | |
| 2023-12-31 | $1,686,172 | 58,568 | Shares | Sole | 2024-01-22 | |
| 2023-09-30 | $1,911,786 | 57,636 | Shares | Sole | 2023-10-19 | |
| 2023-06-30 | $2,392,525 | 65,227 | Shares | Defined | 2023-07-17 | |
| 2023-03-31 | $2,638,250 | 64,663 | Shares | Defined | 2023-04-28 | |
| 2022-12-31 | $2,547,242 | 49,712 | Shares | Sole | 2023-01-25 | |
| 2022-09-30 | $2,821,994 | 64,488 | Shares | Defined | 2022-10-12 | |
| 2022-06-30 | $3,451,623 | 65,833 | Shares | Sole | 2022-07-22 | |
| 2022-03-31 | $3,473,093 | 67,087 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $2,292,616 | 38,825 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $1,707,626 | 39,703 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $3,766,761 | 96,189 | Shares | Sole | 2021-08-02 | |
| 2021-03-31 | $3,511,991 | 96,936 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $3,520,876 | 95,650 | Shares | Sole | 2021-02-05 | |
| 2020-09-30 | $3,516,040 | 95,805 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $3,329,386 | 101,816 | Shares | Sole | 2020-08-06 | |
| 2020-03-31 | $3,412,996 | 104,565 | Shares | Defined | 2020-05-07 | |
| 2020-03-31 | $2,000,829 | 61,300 | Call | Sole | 2020-05-07 | |
| No filing history on record for this holder in this stock. | ||||||